Загрузка...

An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trial

BACKGROUND: The number of injections in the dose escalation of subcutaneous immunotherapy (SCIT) is small for some currently used hypoallergenic allergoids, but can still be inconvenient to patients and can impair compliance. The aim of this trial was to compare safety and tolerability of an acceler...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Transl Allergy
Главные авторы: Chaker, A. M., Al-Kadah, B., Luther, U., Neumann, U., Wagenmann, M.
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2016
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4736162/
https://ncbi.nlm.nih.gov/pubmed/26839682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13601-016-0093-z
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!